Keywords: متابولیزه کننده متوسط; Cl; clearance; CYP; cytochrome P450; ECG; electrocardiogram; ECMO; extracorporeal membrane oxygenation; EM; extensive metabolizer; ICU; intensive care unit; IM; intermediate metabolizer; MR; metabolic ratio; PM; poor metabolizer; t1/2; elimination half-li
مقالات ISI متابولیزه کننده متوسط (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متابولیزه کننده متوسط; ACS; acute coronary syndrome; PCI; percutaneous coronary intervention; DNA; deoxyribonucleic acid; SNPs; single nucleotide polymorphisms; CV death; cardiovascular death; MI; myocardial infarction; EM; extensive metabolizer; IM; intermediate metabolizer; P
Is CYP2D6 phenotype predictable from CYP2D6 genotype?
Keywords: متابولیزه کننده متوسط; CNV; copy number variation; CYP; cytochrome P450; EM; extensive metabolizer; IM; intermediate metabolizer; PCR; polymerase chain reaction; PM; poor metabolizer; SNP; single nucleotide polymorphism; UM; ultra-rapid metabolizer; CYP2D6 genotype; Genetic pol
CYP2D6 (C2850T, G1846A, C100T) polymorphisms, haplotypes and MDR analysis in predicting coronary artery disease risk in north-west Indian population: A case-control study
Keywords: متابولیزه کننده متوسط; μl; microlitre; A; adenine; BMI; body mass index; bp; basepair; C; cytosine; CAD; coronary artery disease; CI; confidence intervals; CNS; central nervous system; CVC; cross validation consistency; CYP2D6; cytochrome P450 2D6; EDTA; ethylenediaminetetra a
Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction
Keywords: متابولیزه کننده متوسط; CAR; constitutive androstane receptor; CI; confidence interval; CYP; cytochrome P450; EM; extensive metabolizer; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; GR; glucocorticoid receptor; IM; intermediate metabolizer; PCR; polymerase chain reaction; PM
Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics
Keywords: متابولیزه کننده متوسط; ADH; alcohol dehydrogenase; CDC; Centers for Disease Control and Prevention; CYP; cytochrome P450; del; deletion; EDDP; 2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolidine; EM; extensive metabolizer; EMDP; 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline; FDA; Food and
Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes
Keywords: متابولیزه کننده متوسط; RO; receptor occupancy; EPS; extrapyramidal symptoms; PK; pharmacokinetic; PD; pharmacodynamic; EM; extensive metabolizer; IM; intermediate metabolizer; PM; poor metabolizer; PBPKPD; physiology-based pharmacokinetic and pharmacodynamic; P-gp; P-glycoprote
Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels
Keywords: متابولیزه کننده متوسط; CYP2D6; Luminex; Activity score; Risperidone; Autism spectrum disorder; CYP2D6; Cytochrome P450 2D6; PM; poor metabolizer; IM; intermediate metabolizer; EM; extensive metabolizer; UM; ultra-rapid metabolizer; ASD; autism spectrum disorder; F; function; DF
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Keywords: متابولیزه کننده متوسط; Biotransformation; Cytochrome P450 monooxygenase; NADPH:cytochrome P450 reductase; Pharmacogenetics; Polymorphism; Xenobiotic; ADME; absorption, distribution, metabolism, excretion; ADR; adverse drug reaction; AhR; aromatic hydrocarbon receptor; CNV; copy
Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype
Keywords: متابولیزه کننده متوسط; Stomach; PPI; Drug Interactions; Cardiovascular; AC; aspirin and clopidogrel; ARU; aspirin reaction unit; CYP2C19; S-mephenytoin 4â²-hydroxylase; GSRS; Gastrointestinal Symptom Rating Scale; IM; intermediate metabolizer; IPA; inhibition of platelet aggre
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
Keywords: متابولیزه کننده متوسط; CYP2C19; Helicobacter pylori; Pharmacogenomics; Proton pump inhibitor; Rapid metabolizer; Intermediate metabolizer; Poor metabolizer;
Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence
Keywords: متابولیزه کننده متوسط; CYP2D6; Methamphetamine; Amphetamine; Dependence; Intermediate metabolizer; Case-control association study
The AmpliChip CYP450 Test: Principles, Challenges, and Future Clinical Utility in Digestive Disease
Keywords: متابولیزه کننده متوسط; ADR; adverse drug reaction; IBS-C; constipation-predominant irritable bowel syndrome; CYP450; cytochrome P450; IBS-D; diarrhea-predominant irritable bowel syndrome; EM; extensive metabolizer; GERD; gastroesophageal reflux disease; IBS; irritable bowel syn
Influence of CYP2C19 Polymorphism and Helicobacter pylori Genotype Determined From Gastric Tissue Samples on Response to Triple Therapy for H pylori Infection
Keywords: متابولیزه کننده متوسط; CI; confidence interval; 13C-UBT; 13C-urea breath test; CYP2C19; S-mephenytoin 4â²-hydroxylase; DU; duodenal ulcer; GU; gastric ulcer; IM; intermediate metabolizer; MALT; mucosa-associated lymphoid tissue; MIC; minimum inhibitory concentration; PCR; poly
Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics
Keywords: متابولیزه کننده متوسط; 5-FU; 5-fluorouracil; 5-HTT; serotonin transporter; 5-HTTLPR; serotonin gene-linked polymorphic region; 6-MP; 6-mercaptopurine; 6-TG; 6-thioguanine; ABCB; ATP-binding cassette (ABC), subfamily B; ACE; angiotensin I converting enzyme (peptidyl-dipeptidase